UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Relapsed/Refractory Multiple Myeloma
Related studies linked through entity extraction aliases.
Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Status
- RECRUITING
- Phase
- PHASE1
Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cevostamab Following CAR T Cell Therapy for RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Universal BCMA-targeted LUCAR-B68 Cells in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Long-Term Follow-up Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1